Role and Mutational Heterogeneity of the p53 Gene in Hepatocellular Carcinoma

Cancer Research

Volumn 53, Issue 2, 1993, Pages 368-372

  Nishida, Naoshi ^a   Fukuda, Yoshihiro ^a   Kokuryu, Hiroyuki ^a   Toguchida, Junya ^a   Yandell, David W ^b   Ikenega, Mituo ^a   Imura, Hiroo ^a   Ishizaki, Kanji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL MUTAGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME 17P; CHROMOSOME MAP; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INTRON; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; GENES, P53; GENETIC MARKERS; HUMAN; JAPAN; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN P53; SUPPORT, NON-U.S. GOV'T;

EID: 0027393921     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Finlay, C.A., Hinds, P.W., and Levine, A.J. The p. 3 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
2. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C., and Vogelstein, B. Mutations in the p. 3 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708, 1989.
3. Bressac, B., Galvin, K.M., Liang, T.J., Isselbacher, K.J., Wands, J.R., and Ozturk, M. Abnormal structure and expression of p. 3 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 1973-1977, 1990.
4. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C. Mutational hotspot in the p. 3 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-128, 1991.
5. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p. 3 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
6. Ozturk, M., et al. p. 3 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338: 1356-1359, 1991.
7. Murakami, Y., Hayashi, K., Hirohashi, S., and Sekiya, T. Aberrations of the tumor suppressor p. 3 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51: 5520-5525, 1991.
8. Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., and Hirohashi, S. Mutation pattern of the p. 3 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res., 52: 3674-3678, 1992.
9. Baker, S.J., Preisinger, A.C., Jessup, J.M., Paraskeva, C., Markowitz, S., Willson, J.K.V., Hamilton, S., and Vogelstein, B. p. 3 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 1111-1122, 1990.
10. Nishida, N., Fukuda, Y., Kokuryu, H., Sadamoto, T., Isowa, G., Honda, K., Yamaoka, Y., Ikenaga, M., Imura, H., and Ishizaki, K. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int. J. Cancer, 51: 862-868, 1992.
11. Frankel, R.H., Bayona, W., Koslow, M., and Newcomb, E.W. p. 3 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res., 52: 1427-1433, 1992.
12. Okamoto, A., Sameshima, Y., Yokoyama, S., Terashima, Y., Sugimura, T., Terada, M., and Yokota, J. Frequent allelic losses and mutations of the p. 3 gene in human ovarian cancer. Cancer Res., 51: 5171-5176, 1991.
13. Biegel, J.A., Burk, C.D., Barr, F.G., and Emanuel, B.S. Evidence for a 17p tumor related locus distinct from p. 3 in pediatric primitive neuroectodermal tumors. Cancer Res., 52: 3391-3395, 1992.
14. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mit-sunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K., and Nakamura, Y Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51: 89-93, 1991.
15. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-7189, 1990.
16. Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., and Weiss, R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell, 62: 599-608, 1990.
17. Leone, A., McBride, O. W., Weston, A., Wang, M.G., Anglard, P., Cropp, C.S., Goepel, J.R., Lidereau, R., Callahan, R., Linehan, W.M., Rees, R.C., Harris, C.C., Liotta, L.A., and Steeg, P.S. Somatic allelic deletion of nm23 in human cancers. Cancer Res., 57: 2490-2493, 1991.
18. White, J.J., Ledbetter, D.H., Eddy, R.L., Shows, T.B., Stewart, D.A., Nuell, M.J., Friedman, V., Wood, C.M., Owens, G.A., McClung, J.K., Danner, D.B., and Morton, C.C. Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism. Genomics, 11: 228-230, 1991.
19. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Ed. 3, pp. 22-23. Tokyo: Kanehara Press, 1992.
20. Edmondson, H.A., and Steiner, P.E. Primary carcinoma of the liver. A study of 100 cases among 48, 900 necropsies. Cancer (Phila.), 7: 462-503, 1954.
21. The Eleventh International Workshop on Human Gene Mapping, Human Gene Mapping 11. Cytogenet. Cell Genet., 58: 1-2200, 1991.
22. Buchman, V.L., Chumakov, P.M., Ninkina, N.N., Samarina, O.P., and Georgiev, G.P. A variation in the structure of the protein-cording region of the human p. 3 gene. Gene, 70: 245-252, 1988.
23. Toguchida, J., Yamaguchi, T., Ritchie, B., Beauchamp, R.L., Dayton, S.H., Herrera, G.E., Yamamuro, T., Kotoura, Y., Sasaki, M.S., Little, J.B., Weichselbaum, R.R., Ishizaki, K., and Yandell, D.W. Mutation spectrum of the p. 3 gene in bone and soft tissue sarcomas. Cancer Res., 52: 6194-6199, 1992.
24. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
25. Kress, S., Jahn, U.R., Buchmann, A., Bannasch, P., and Schwarz, M. p. 3 mutation in human hepatocellular carcinomas from Germany. Cancer Res., 52: 3220-3223, 1992.
26. Mellon, I., Spivak, G., and Hanawalt, P.C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell, 51: 241-249, 1987.
27. Miller, C.W., Simon, K., Aslo, A., Kok, K., Yokota, J., Buys, C.H.C.M., Terada, M., and Koeffler, H.P. p. 3 mutations in human lung tumors. Cancer Res., 52: 1695-1698, 1992.
28. Wakabayashi, K., Nagao, M., Esumi, H., and Sugimura, T. Food-derived mutagens and carcinogens. Cancer Res., 52 (Suppl.): 2092s-2098s, 1992.
29. Harris, C.C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51 (Suppl.): 5023s-5044s, 1991.
30. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M.L., Cavanee, W., and Vogelstein, B. Clonal expansion of p. 3 mutant cells is associated with brain tumor progression. Nature (Lond.), 355: 846-847, 1992.
31. Herskowitz, I. Functional inactivation of genes by dominant-negative mutations. Nature (Lond.), 329: 219-222, 1987.